Inhibitors of isoprenoid synthesis for antibacterial therapy
Award amount
$145,205Program and phase
SBIR · Phase IAward year
2013Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Specific Diagnostics, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- N7RLPSHLM4E5
- Solicitation number
- PA12-088
- Topic code
- NCI
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Rapid bacteriophage susceptibility testing using small molecule sensor technology
- Rapid Low Cost Phenotypic Antibiotic Susceptibility Testing
- Rapid Low Cost Phenotypic Antibiotic Susceptibility Testing.
- Combining faster detection with ID: a new paradigm for mycobacterial culture
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis
Research funding history
5 SBIR/STTR records share this UEI (2013–2021). Reported award amounts total $9,341,541. Reported amounts are not federal obligations.
Phases: Phase II – Direct to Phase II, Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense